tiprankstipranks
COSMO Pharmaceuticals N.V. (GB:0RGI)
:0RGI
UK Market

COSMO Pharmaceuticals N.V. (0RGI) Financial Statements

Compare
9 Followers

COSMO Pharmaceuticals N.V. Financial Overview

COSMO Pharmaceuticals N.V.'s market cap is currently CHF1.11B. The company's EPS TTM is CHF4.154; its P/E ratio is 15.81; and it has a dividend yield of 2.96%. COSMO Pharmaceuticals N.V. is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is CHF3.63. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue
Gross Profit$ 83.33M$ 49.93M$ 50.51M$ 53.25M$ 59.40M
Operating Income$ 28.06M$ 11.10M$ 6.91M$ -12.31M$ -16.62M
EBITDA$ 47.49M$ 40.36M$ 7.84M$ -6.72M$ -11.93M
Net Income$ 17.23M$ 21.67M$ -7.90M$ -24.42M$ -18.01M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 759.59M$ 805.56M$ 596.16M$ 585.16M$ 625.69M
Total Debt$ 173.60M$ 169.92M$ 168.14M$ 164.84M$ 158.15M
Net Debt$ -67.36M$ -52.29M$ -44.71M$ -103.37M$ -191.29M
Total Liabilities$ 295.80M$ 292.88M$ 196.04M$ 191.43M$ 180.83M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ 25.92M$ 4.11M$ 4.90M$ -36.16M$ -19.84M
Operating Cash Flow$ 33.23M$ 12.61M$ 12.98M$ -18.85M$ -10.16M
Investing Cash Flow
Financing Cash Flow
Currency in USD

COSMO Pharmaceuticals N.V. Earnings and Revenue History

COSMO Pharmaceuticals N.V. Debt to Assets

COSMO Pharmaceuticals N.V. Cash Flow

COSMO Pharmaceuticals N.V. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis